Legend Biotech (LEGN) Income from Non-Controlling Interests (2020 - 2025)
Legend Biotech (LEGN) posted Income from Non-Controlling Interests of $124.2 million for Q2 2025, up 104.52% on a QoQ basis from $60.7 million in Q1 2025, and up 1278.93% year-over-year from $9.0 million in Q2 2024.
Legend Biotech (LEGN) Income from Non-Controlling Interests (2020 - 2025) Analysis & Trends
Legend Biotech's Income from Non-Controlling Interests history runs 6 years deep, the most recent figure standing at $124.2 million for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 124.20 Mn |
| Mar 31, 2025 | 60.73 Mn |
| Sep 30, 2024 | 61.90 Mn |
| Jun 30, 2024 | -10.54 Mn |
| Mar 31, 2024 | -47.99 Mn |
| Sep 30, 2023 | -20.24 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Mar 31, 2023 | 13.51 Mn |
| Sep 30, 2022 | 221.33 Mn |
| Jun 30, 2022 | -181.41 Mn |
| Mar 31, 2022 | -38.78 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | 79.86 Mn |
| Mar 31, 2021 | -76.55 Mn |
| Sep 30, 2020 | -586,000.00 |